ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,851.94
0.46%
Gold vs US Dollar
2,323.66
1.30%
Brent Oil
83.315
0.23%
Bitcoin
63,179.78
-1.28%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aimmune Therapeutics Inc (AIMT)

  7. Aimmune Therapeutics Inc (AIMT) News

Aimmune Therapeutics (AIMT)

Aimmune Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AIMT
DateTimeSourceHeadlineSymbolCompany
25/02/202114:00Business WireAimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 YearsNASDAQ:AIMTAimmune Therapeutics Inc
16/02/202121:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AIMTAimmune Therapeutics Inc
21/12/202006:15Business WireEuropean Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EUNASDAQ:AIMTAimmune Therapeutics Inc
23/10/202018:12Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AIMTAimmune Therapeutics Inc
19/10/202022:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
14/10/202021:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:31Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:31Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:30Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:30Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:30Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202022:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202015:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202015:45Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202015:45Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202014:15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:AIMTAimmune Therapeutics Inc
13/10/202007:15Dow Jones NewsNestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With SubsidiaryNASDAQ:AIMTAimmune Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AIMT

Your Recent History

LSE
POS
Plexus
LSE
RR.
Rolls-royce
LSE
SBTX
Skinbiotherapeutics
LSE
SRSP
Sirius Petroleum
LSE
HUM
Hummingbird Resources
LSE
SCE
Surface Transforms
LSE
BIRD
Blackbird
LSE
AAU
Ariana Resources
LSE
AGL
Angle
LSE
ENET
Ethernity Networks
LSE
CHLL
Chill Brands
LSE
LLOY
Lloyds Banking
LSE
ASC
Asos
LSE
SOLG
Solgold
LSE
BARC
Barclays
LSE
EEE
Empire Metals
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved